Common-Size Income Statement
Paying users area
Try for free
GlaxoSmithKline PLC pages available for free this week:
- Balance Sheet: Assets
- Cash Flow Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- Analysis of Solvency Ratios
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
The data is hidden behind: . Unhide it.
Get 1-month access to GlaxoSmithKline PLC for $22.49, or
get full access to the entire website for at least 3 months from $62.19.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).
Income statement item | Description | The company |
---|---|---|
Operating profit | The net result for the period of deducting operating expenses from operating revenues. | GlaxoSmithKline PLC operating profit as a percentage of turnover decreased from 2012 to 2013 and from 2013 to 2014. |
Profit before taxation | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | GlaxoSmithKline PLC profit before taxation as a percentage of turnover decreased from 2012 to 2013 and from 2013 to 2014. |
Profit attributable to shareholders | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | GlaxoSmithKline PLC profit attributable to shareholders as a percentage of turnover increased from 2012 to 2013 but then decreased significantly from 2013 to 2014. |